These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27089280)

  • 1. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
    Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
    PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.
    Wang M; Zhang Q; Zhao X; Dong G; Li C
    Crit Care; 2014 Nov; 18(6):634. PubMed ID: 25407832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
    Bojic S; Kotur-Stevuljevic J; Kalezic N; Stevanovic P; Jelic-Ivanovic Z; Bilanovic D; Memon L; Damnjanovic M; Kalaba Z; Simic-Ogrizovic S
    Tohoku J Exp Med; 2015 Oct; 237(2):103-9. PubMed ID: 26399271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
    Lorente L; Martín MM; Labarta L; Díaz C; Solé-Violán J; Blanquer J; Orbe J; Rodríguez JA; Jiménez A; Borreguero-León JM; Belmonte F; Medina JC; Llimiñana MC; Ferrer-Agüero JM; Ferreres J; Mora ML; Lubillo S; Sánchez M; Barrios Y; Sierra A; Páramo JA
    Crit Care; 2009; 13(5):R158. PubMed ID: 19799791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery.
    Bojic S; Kotur-Stevuljevic J; Aleksic A; Gacic J; Memon L; Simic-Ogrizovic S
    Dis Markers; 2018; 2018():5064684. PubMed ID: 29861795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
    Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
    J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance on serum intestinal fatty acid binding protein and D-lactic acid levels in early intestinal injury of patients with sepsis].
    Zhang X; Liu D; Wang Y; Yan J; Yang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):545-550. PubMed ID: 31198137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Matrix Metalloproteinases and Their Inhibitors for Mortality in Septic Patients: A Cohort Study.
    Serrano-Gomez S; Burgos-Angulo G; Niño-Vargas DC; Niño ME; Cárdenas ME; Chacón-Valenzuela E; McCosham DM; Peinado-Acevedo JS; Lopez MM; Cunha F; Pazin-Filho A; Ilarraza R; Schulz R; Torres-Dueñas D
    J Intensive Care Med; 2020 Jan; 35(1):95-103. PubMed ID: 28931365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.
    Hästbacka J; Fredén F; Hult M; Bergquist M; Wilkman E; Vuola J; Sorsa T; Tervahartiala T; Huss F
    PLoS One; 2015; 10(5):e0125918. PubMed ID: 25945788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.
    Hoffmann U; Bertsch T; Dvortsak E; Liebetrau C; Lang S; Liebe V; Huhle G; Borggrefe M; Brueckmann M
    Scand J Infect Dis; 2006; 38(10):867-72. PubMed ID: 17008230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis.
    Jones TK; Reilly JP; Anderson BJ; Miano TA; Dunn TG; Weisman AR; Agyekum R; Feng R; Ittner CAG; Shashaty MGS; Meyer NJ
    Shock; 2022 Jan; 57(1):41-47. PubMed ID: 34265829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.
    Lauhio A; Hästbacka J; Pettilä V; Tervahartiala T; Karlsson S; Varpula T; Varpula M; Ruokonen E; Sorsa T; Kolho E
    Pharmacol Res; 2011 Dec; 64(6):590-4. PubMed ID: 21742038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
    Forsblom E; Tervahartiala T; Ruotsalainen E; Järvinen A; Sorsa T
    PLoS One; 2021; 16(5):e0252046. PubMed ID: 34043679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis.
    Wereszczynska-Siemiatkowska U; Siemiatkowski A; Swidnicka-Siergiejko A; Mroczko B; Dabrowski A
    Z Gastroenterol; 2015 Mar; 53(3):199-204. PubMed ID: 25775169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock.
    Jo YH; Kim K; Lee JH; Rhee JE; Lee JH; Kang KW; Rim KP; Hwang SS; Park HM
    Am J Emerg Med; 2012 Nov; 30(9):1749-55. PubMed ID: 22463971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
    Lorente L; Martín MM; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Borreguero-León JM; Orbe J; Rodríguez JA; Jiménez A; Páramo JA
    PLoS One; 2014; 9(4):e94318. PubMed ID: 24727739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.
    Bieniaś B; Sikora P
    Dis Markers; 2020; 2020():9520309. PubMed ID: 32670438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 after burn injury.
    Nagy B; Szélig L; Rendeki S; Loibl C; Rézmán B; Lantos J; Bogár L; Csontos C
    J Crit Care; 2015 Feb; 30(1):162-6. PubMed ID: 25155253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.